Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yuste

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Emerging Microbes & Infections|September 20, 2021
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responsesBelén Aparicio, Noelia Casares, Josune Egea, et al.
The Journal of Infectious Diseases|August 12, 2020
Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney TransplantationAurora Páez-Vega, Sara Cantisán, Maria L Agüera, et al.
Eclinicalmedicine|January 26, 2021
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialCarlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2021
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical TrialAurora Páez-Vega, Belén Gutiérrez-Gutiérrez, Maria L Agüera, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Emerging Microbes & Infections|September 20, 2021
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responsesBelén Aparicio, Noelia Casares, Josune Egea, et al.
The Journal of Infectious Diseases|August 12, 2020
Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney TransplantationAurora Páez-Vega, Sara Cantisán, Maria L Agüera, et al.
Eclinicalmedicine|January 26, 2021
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trialCarlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2021
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical TrialAurora Páez-Vega, Belén Gutiérrez-Gutiérrez, Maria L Agüera, et al.
Pageof 10